Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intravenous Adenosine on neuro-psychological dysfunction post coronary artery bypass surgery
2005-002794-79Phase 4Completed
- Sponsor
- Swansea Bay University Health Board
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of adenosine in Postoperative cognitive dysfunction (POCD), sponsored by Swansea Bay University Health Board. Primary endpoint: Neuropsychological dysfunction after CABG surgery. Started Jan 2006; status: completed.
02
Drugs
adenosine
03
Conditions
Postoperative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on 2005-002794-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002794-79.